MedPath

Toric Intraocular Lens Implantation in Pediatric Cataract

Not Applicable
Active, not recruiting
Conditions
Cataract Congenital
Astigmatism
IOL
Interventions
Procedure: congenital/pediatric cataract surgery
Device: Toric IOLs
Device: Non-Toric IOLs
Registration Number
NCT06294795
Lead Sponsor
Kazakh Eye Research Institute
Brief Summary

To evaluate the visual and refractive outcomes after an intraocular lens (IOL) implantation in pediatric eyes with cataract and preexisting corneal astigmatism

Detailed Description

This single-center, single-blinded, prospective, randomized controlled trial was performed at two sites of Kazakh Eye Research Institute.

Children with pediatric cataract and corneal astigmatism were included and randomized to two groups for pediatric cataract surgery with toric and non-toric IOLs implantation. The uncorrected and corrected distance visual acuity, near visual acuity, keratometry data, and residual astigmatism were evaluated.

The purpose of this study is to evaluate the visual and refractive outcomes after a toric IOL implantation in pediatric eyes with cataract and preexisting corneal astigmatism.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Toriccongenital/pediatric cataract surgeryA folding hydrophobic acrylic intraocular lens (IOL) AcrySof IQ SN60WF and Clareon SY60WF
ToricToric IOLsA folding hydrophobic acrylic intraocular lens (IOL) AcrySof IQ SN60WF and Clareon SY60WF
Non-toriccongenital/pediatric cataract surgeryA folding hydrophobic acrylic IOLs AcrySof IQ Toric SN6ATx and Clareon Toric CNW0Tx
Non-toricNon-Toric IOLsA folding hydrophobic acrylic IOLs AcrySof IQ Toric SN6ATx and Clareon Toric CNW0Tx
Primary Outcome Measures
NameTimeMethod
Uncorrected (UCDVA) and corrected (CDVA) distance visual acuityrecorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year)

measured using the Lea symbol visual acuity chart or the Early Treatment of Diabetic Retinopathy Study (ETDRS) chart according to the patient\'s age

Uncorrected (UCNVA) and corrected (CNVA) near visual acuityrecorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year)

measured using the Lea symbol visual acuity chart or the ETDRS chart for near according to the patient\'s age

Refraction measurementsrecorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year)

obtained with KR-1W Wavefront Analyzer

Secondary Outcome Measures
NameTimeMethod
Keratometry measurementsrecorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year)

obtained with KR-1W Wavefront Analyzer

Trial Locations

Locations (1)

Kazakh Eye Research Institute

🇰🇿

Astana, Kazakhstan

© Copyright 2025. All Rights Reserved by MedPath